Pregled bibliografske jedinice broj: 1237396
Gastrointestinal Manifestations in Hospitalized Children With Acute SARS-CoV-2 Infection and Multisystem Inflammatory Condition: An Analysis of the VIRUS COVID-19 Registry
Gastrointestinal Manifestations in Hospitalized Children With Acute SARS-CoV-2 Infection and Multisystem Inflammatory Condition: An Analysis of the VIRUS COVID-19 Registry // The Pediatric infectious disease journal, 41 (2022), 9; 751-758 doi:10.1097/INF.0000000000003589 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1237396 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Gastrointestinal Manifestations in Hospitalized
Children With Acute SARS-CoV-2 Infection and
Multisystem Inflammatory Condition: An Analysis of
the VIRUS COVID-19 Registry
Autori
Sayed, IA ; Bhalala, U ; Strom, L ; Tripathi, S ; Kim, JS ; Michaud, K ; ... ; Kovacevic, Tanja ; Markic, Josko ; Catipovic Ardalic, Tatjana ; Polic, Branka ; VIRUS Investigators
Kolaboracija
VIRUS Investigators
Izvornik
The Pediatric infectious disease journal (0891-3668) 41
(2022), 9;
751-758
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
gastrointestinal ; coronavirus disease 2019 ; pediatric ; critical illness
Sažetak
Background: Describe the incidence and associated outcomes of gastrointestinal (GI) manifestations of acute coronavirus disease 2019 (COVID-19) and multisystem inflammatory syndrome in hospitalized children (MIS-C). Methods: Retrospective review of the Viral Infection and Respiratory Illness Universal Study registry, a prospective observational, multicenter international cohort study of hospitalized children with acute COVID-19 or MIS-C from March 2020 to November 2020. The primary outcome measure was critical COVID-19 illness. Multivariable models were performed to assess for associations of GI involvement with the primary composite outcome in the entire cohort and a subpopulation of patients with MIS-C. Secondary outcomes included prolonged hospital length of stay defined as being >75th percentile and mortality. Results: Of the 789 patients, GI involvement was present in 500 (63.3%). Critical illness occurred in 392 (49.6%), and 18 (2.3%) died. Those with GI involvement were older (median age of 8 yr), and 18.2% had an underlying GI comorbidity. GI symptoms and liver derangements were more common among patients with MIS-C. In the adjusted multivariable models, acute COVID-19 was no associated with the primary or secondary outcomes. Similarly, despite the preponderance of GI involvement in patients with MIS-C, it was also not associated with the primary or secondary outcomes. Conclusions: GI involvement is common in hospitalized children with acute COVID-19 and MIS- C. GI involvement is not associated with critical illness, hospital length of stay or mortality in acute COVID-19 or MIS-C.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
KBC Split,
Medicinski fakultet, Split
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE